News

Artificial intelligence is becoming an important part of the pharmaceutical sector. It is being used in research, drug development, clinical trials, manufacturing and regulatory work. A McKinsey study ...
The Air Force has issued guidance on how transgender Airmen and Guardians will be involuntarily discharged, making it the ...
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark ...
When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
Shoppers at Checkers supermarkets in South Africa could soon be cruising the aisles with "smart" trolleys that let them know ...
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.
Michela Cimberle, senior staff writer for Healio | OSN, won an APEX Award of Excellence for a 2024 exclusive story on diversity in clinical trials and efforts to improve health equality. Cimberle ...
A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing on MRIs after the breakthrough cancer treatment.
Follow live results from 2025 All American Oaks and All American Derby trials. There will be four Oaks trials and six Derby trials.
After being found guilty by a jury in New York's Southern District, Roman Storm could face up to 45 years in prison at sentencing.
Nebraska Medicine is testing a new multiple sclerosis treatment for the first time in the world.